Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
BACE Knockouts Show More Synaptic Troubles
5 September 2008. The hopes for treating Alzheimer disease by inhibiting the amyloid-producing enzyme β-secretase (BACE) rest largely on results obtained in mice, particularly the finding that mice lacking the BACE1 gene lose essentially all their amyloid-β peptide production and become resistant to developing AD. As a bonus, the loss of BACE1 appeared to cause no gross physical or physiological abnormalities, raising the prospect that BACE inhibitors might come with few side effects.

However, mice sans BACE1 are not totally unscathed. Detailed studies on the knockout mice, including work from Fiona Laird and Philip Wong of the Johns Hopkins University in Baltimore, Maryland, revealed that BACE knockouts had problems with synaptic function and plasticity, and behavioral problems as well (see ARF related news story; Laird et al., 2005; and Harrison et al., 2003). BACE knockout mice have a surfeit of myelination in the peripheral nervous system (see ARF related news story), which may be related to a lack of cleavage of the neurotrophic factor neuregulin (NRG). More recent work, also from the Wong lab, revealed that the BACE1 knockouts displayed several behaviors associated with schizophrenia in people (see ARF related news story).

A new report extends the synaptic story, showing that BACE1 knockout mice lose the capacity for long-term potentiation in mossy fiber terminals, the site of the highest BACE protein levels in the mouse hippocampus. The results, from Hey-Kyoung Lee and colleagues at the University of Maryland at College Park, along with Laird and Wong, augment the idea that wholesale inhibition of BACE may be less benign than many had hoped. The work appears in a Brief Communication in the August 27 Journal of Neuroscience.

Previous work on the synaptic effects of BACE deficiency in mice had focused on changes in the CA1 region of the hippocampus, but the BACE1 protein is most abundant in the mossy fibers that synapse onto CA3 neurons. Looking specifically at these neurons, first author Hui Wang and colleagues measured an increase in paired pulse facilitation in hippocampal slices from the knockouts, which suggests a reduction in presynaptic neurotransmitter release. In addition, they found that activity-dependent long-term potentiation at mossy fiber synapses was abolished in the BACE knockouts. The effects on LTP also seemed to stem from presynaptic problems, because downstream calcium-initiated signaling appeared to be intact in BACE1 knockouts. Indeed, the induction of LTP could be rescued by increasing extracellular calcium concentrations.

“We found that BACE knockouts display severe deficits in presynaptic function at mossy fiber synapses in CA3,” the authors conclude. “These results suggest that BACE1 function is critical for normal synaptic transmission and plasticity, especially activity-dependent potentiation, at these synapses.” Not clear, they say in the paper, is whether this involves the loss of amyloid precursor protein processing, or if the effects might involve other substrates.

“Our results indicate that a complete inhibition of BACE1 activity is deleterious for neuronal function,” the authors write. However, they suggest that enhancing presynaptic calcium might be a way to alleviate synaptic effects and behavioral phenotypes associated with BACE1 inhibition.

One prominent BACE substrate is neuregulin (NRG), a membrane-tethered neurotrophic factor that signals via ErbB family receptors. Modulation of NRG/ErbB signaling at synapses is one way that BACE1 activity might affect synaptic function, the authors write. The BACE-NRG connection comes up in another context, too, which is the regulation of myelination of axons. Neuregulin acts in the peripheral nervous system to control the development of Schwann cells and stimulate them to wrap axons with a myelin sheath. Indeed, a failure of NRG cleavage in BACE knockout mice explains their phenotype of loss of peripheral myelin (Willem et al., 2006).

However, the potential demyelinating effects of NRG inhibition may not translate into the CNS, according to new data from Markus Schwab and Klaus Armin Nave at the Max Planck Institute of Experimental Medicine in Goettingen, Germany. In their paper, published in the August 28 issue of Neuron, the researchers led by first authors Bastian Brinkmann and Amit Agarwal show that in brain-specific neuregulin or ErbB knockout mice, myelination proceeds normally for CNS neurons. The results reveal a surprising divergence of function for the NRG1/ErbB pathways between Schwann cells in the periphery and oligodendrocytes in the CNS. BACE knockout mice have been reported to have deficits in CNS myelination (Hu et al., 2006), but the current work suggests that may not be explained by a defect in neuregulin processing. It appears that, just as in the case of the synaptic effects of BACE inhibition, the responsible targets for myelination are still at large.—Pat McCaffrey.

References:
Wang H, Song L, Laird F, Wong PC, Lee H-K. BACE1 knockouts display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J. Neurosci. 2008 August 27;28(35):8677-8681. Abstract

Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Müller T, Wende H, Stassart RM, Nawaz S, Humml C, Velanac V, Radyushkin K, Goebbels S, Fischer TM, Franklin RJ, Lai C, Ehrenreich H, Birchmeier C, Schwab MH, Nave KA. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron. 2008 Aug 28;59(4):581-95. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad